trending Market Intelligence /marketintelligence/en/news-insights/trending/MoEXXoS2FbAqZo0MUNsk3g2 content esgSubNav
In This List

Matinas BioPharma appoints director

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Matinas BioPharma appoints director

Matinas BioPharma Holdings Inc. appointed Matthew Wikler to its board, replacing current member Stefano Ferrari, effective Jan. 1, 2018.

Wikler currently serves as the principal of Infectious Disease Technology Development Consulting.